Voyageur Pharmaceuticals Ltd
XTSX:VM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Voyageur Pharmaceuticals Ltd
Other Current Assets
Voyageur Pharmaceuticals Ltd
Other Current Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Voyageur Pharmaceuticals Ltd
XTSX:VM
|
Other Current Assets
CA$47.9k
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Other Current Assets
$868m
|
CAGR 3-Years
3%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-1%
|
|
|
X
|
Xenon Pharmaceuticals Inc
NASDAQ:XENE
|
Other Current Assets
$10.4m
|
CAGR 3-Years
13%
|
CAGR 5-Years
28%
|
CAGR 10-Years
19%
|
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Other Current Assets
CA$6.5m
|
CAGR 3-Years
51%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
|
Spectral Medical Inc
TSX:EDT
|
Other Current Assets
CA$640k
|
CAGR 3-Years
32%
|
CAGR 5-Years
10%
|
CAGR 10-Years
16%
|
|
|
Cipher Pharmaceuticals Inc
TSX:CPH
|
Other Current Assets
$1.4m
|
CAGR 3-Years
91%
|
CAGR 5-Years
15%
|
CAGR 10-Years
-8%
|
|
Voyageur Pharmaceuticals Ltd
Glance View
Voyageur Pharmaceuticals Ltd. engages in exploring and development of barite, iodine, and fullerene Active Pharmaceutical Ingredient (API) minerals. The company is headquartered in Calgary, Alberta. The company went IPO on 2012-05-18. The firm is focused on the development of barite and iodine Active Pharmaceutical Ingredients (API) and imaging contrast agents for the medical radiology marketplace. The company owns a 100% interest in three barium sulfate (barite) projects. The firm operates through its subsidiaries, Voyageur Industrial Minerals Ltd. and Voyageur Minerals Inc. The company is focused on developing its barium sulfate project, Frances Creek, in BC, Canada for pharmaceutical barium contrast applications, such as x-radiation, computed tomography scans and magnetic resonance imaging applications. The company also owns mineral brine claims in Utah United States, including Frances Creek, Jubilee Mountain and Pedley Mountain.
See Also
What is Voyageur Pharmaceuticals Ltd's Other Current Assets?
Other Current Assets
47.9k
CAD
Based on the financial report for Aug 31, 2025, Voyageur Pharmaceuticals Ltd's Other Current Assets amounts to 47.9k CAD.
What is Voyageur Pharmaceuticals Ltd's Other Current Assets growth rate?
Other Current Assets CAGR 5Y
-8%
Over the last year, the Other Current Assets growth was -40%. The average annual Other Current Assets growth rates for Voyageur Pharmaceuticals Ltd have been -29% over the past three years , -8% over the past five years .
